Withdrawal of Registration Statement (rw)
August 19 2019 - 9:47AM
Edgar (US Regulatory)
PROPANC
BIOPHARMA, INC.
302,
6 Butler Street
Camberwell,
VIC, 3124 Australia
61
3 9882 0780
August
19, 2019
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street N.E.
Washington,
D.C. 20549
|
Re:
|
Propanc Biopharma, Inc.
|
|
|
Request for Withdrawal
|
|
|
Registration Statement on Form S-1 (File
No. 333-231682)
|
Ladies
and Gentlemen:
Propanc
Biopharma, Inc. (the “Company”) hereby requests the Company’s Registration Statement on Form S-1 (File No. 333-231682)
initially filed with the Securities and Exchange Commission (the “Commission”) on May 23, 2019, as subsequently amended
on June 14, 2019 (together with all exhibits thereto, the “Registration Statement”) be withdrawn.
The
Company has determined at this time not to proceed and requests that the Commission consent to this application on the grounds
that withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated
by paragraph (a) of Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”).
Accordingly,
pursuant to Rule 477 under the Securities Act, the Company hereby requests that the Registration Statement be withdrawn, effective
as of the date hereof or the earliest practicable date.
Should
you have any questions regarding this filing, please do not hesitate to contact the undersigned at 61 3 9882 0780.
|
Sincerely,
|
|
|
|
PROPANC
BIOPHARMA, INC.
|
|
|
|
By:
|
/s/
James Nathanielsz
|
|
Name:
|
James Nathanielsz
|
|
Title:
|
Chief Executive
Officer
|
Propanc Biopharma (PK) (USOTC:PPCB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Propanc Biopharma (PK) (USOTC:PPCB)
Historical Stock Chart
From Apr 2023 to Apr 2024